ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
Dow Jones
38,675.68
1.18%
Brent Oil
82.765
0.00%
Bitcoin
63,731.63
1.34%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Schrodinger Inc (SDGR) Quote

Schrodinger Inc

Schrodinger Inc (SDGR)

NASDAQ
23.68
0.49
(2.11%)
Closed May 04 4:00PM
Delayed by 15 minutes
23.4716
-0.2084
(-0.88%)
After Hours: 6:00PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
23.4716
Bid
21.66
Ask
39.75
Volume
1,016,971
23.595 Day's Range 25.19
20.76 52 Week Range 59.24
Market Cap
1.711B
Previous Close
23.19
Open
23.72
Last Trade
1
@
23.95
Last Trade Time
Financial Volume
$ 24,547,337
VWAP
24.1377
Average Volume (3m)
940,521
Shares Outstanding
72,310,612
Dividend Yield
-
PE Ratio
42.02
Earnings Per Share (EPS)
0.56
Revenue
216.67M
Net Profit
40.72M

About Schrodinger Inc

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the... Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. Schrodinger generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.schrodinger.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Schrodinger Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SDGR. The last closing price for Schrodinger was $23.19. Over the last year, Schrodinger shares have traded in a share price range of $ 20.76 to $ 59.24.

Schrodinger currently has 72,310,612 shares outstanding. The market capitalization of Schrodinger is $1.71 billion. Schrodinger has a price to earnings ratio (PE ratio) of 42.02.

Schrodinger (SDGR) Options Flow Summary

SDGR Options Flow

Overall Flow

Bearish

Net Premium

-1M

Calls / Puts

0.00%

Buys / Sells

200.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

SDGR Latest News

More News

Schrödinger Reports First Quarter 2024 Financial Results

First Quarter Total Revenue of $36.6 Million, Software Revenue of $33.4 Million Announces FDA Clearance of Investigational New Drug Application for SGR-3515, a Novel Wee1/Myt1 Inhibitor SGR-1505...

May 01 2024
Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on April 15, 2024, the company...

April 18 2024
Business Wire

Schrödinger to Announce First Quarter 2024 Financial Results on May 1

Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its first quarter 2024 financial results on...

April 10 2024
Business Wire

Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting

Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today presented the discovery of SGR-1505, its...

March 20 2024
Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on March 15, 2024, the company...

March 19 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

March 07 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

March 05 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

March 05 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

March 05 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

March 05 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.1284-0.5440677966123.626.7522.32120868223.98151633CS
4-2.4184-9.3410583236825.8929.1522.3279794425.08588091CS
12-3.9784-14.493260473627.4533.6322.3294052126.78169349CS
26-2.1184-8.2782336850325.593822.3284974228.61303763CS
52-5.0084-17.585674157328.4859.2420.76102244334.59116553CS
156-52.5284-69.11631578957679.7515.8578154735.89358263CS
260-6.9784-22.917569786530.4511715.8590334246.96542301CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BENFBeneficient
$ 6.8001
(254.17%)
31.01M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M
SHOTWSafety Shot Inc
$ 0.45
(45.16%)
644
AIPArteris Inc
$ 8.185
(38.03%)
1.11M
RGFReal Good Food Company Inc
$ 0.85
(37.32%)
4.26M
MNDRMobile health Network Solutions
$ 3.33
(-84.91%)
18.76M
NUVOHoldco Nuvo Group DG Ltd
$ 2.00
(-57.54%)
1.04M
SPTSprout Social Inc
$ 28.82
(-40.15%)
13.47M
UNITUniti Group Inc
$ 4.441
(-26.35%)
21.07M
IPDNProfessional Diversity Network Inc
$ 1.29
(-24.12%)
662.59k
AAPLApple Inc
$ 183.38
(5.98%)
163.22M
SQQQProShares UltraPro Short QQQ
$ 11.08
(-5.94%)
154.59M
JAGXJaguar Health Inc
$ 0.3164
(7.91%)
142.47M
NKLANikola Corporation
$ 0.6526
(6.55%)
106.88M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M

SDGR Discussion

View Posts
scotsand scotsand 7 months ago
This needs to turn around soon. So oversold.
👍️0
scotsand scotsand 11 months ago
Beast mode
👍️0
scotsand scotsand 12 months ago
Love this ticker
👍️0
scotsand scotsand 1 year ago
Up 20%. Guess was right… adding.
👍️0
scotsand scotsand 1 year ago
Now is the time to add.
👍️0
Porterhouse10 Porterhouse10 2 years ago
Cathy Woods adding
👍️0
nowwhat2 nowwhat2 3 years ago



👍️0
adtime adtime 3 years ago
This was a fun move hope someone followed ;) 8% at peak today ftw
👍️0
adtime adtime 3 years ago
Nice set up if gets into 60
👍️0
ernie44 ernie44 3 years ago
M and A -------------------------
merger looming---microsoft
👍️0
Bucketh3ad Bucketh3ad 4 years ago
Smh
👍️0
chrispy2468 chrispy2468 4 years ago
Any insight to this upward move after hours?
👍️0
canadiansalmongal canadiansalmongal 4 years ago
Very Solid company with HUGE money supporting it...Long term Hold this is a golden ticket going forward $100 PT this time next year!
👍️0
chrispy2468 chrispy2468 4 years ago
Little action AH
👍️0
RodgeDodger RodgeDodger 4 years ago
Still running
👍️0
crudeoil24 crudeoil24 4 years ago
I am not holding shares. It may run some more, plus not everyone is familiar with Citron the beast! > LOL.
👍️0
realfast95 realfast95 4 years ago
yea he exaggerates his long ideas. TLRY,RVLV come to mind
👍️0
crudeoil24 crudeoil24 4 years ago
Citron > will they be shorting tomorrow? Playing off the TSLA hype!

👍️0
chrispy2468 chrispy2468 4 years ago
Bullish
👍️0
TheFinalCD TheFinalCD 4 years ago
https://citronresearch.com/schrodinger-sdgr-taking-drug-discovery-to-the-space-age/
👍️0
realfast95 realfast95 4 years ago
Citron pump

https://twitter.com/CitronResearch/status/1230538195726503942

Citron Research
@CitronResearch
$SDGR the most important IPO past 5 years. Taking drug discovery to "space age". The parallels to an early stage $TSLA are too obvious to ignore. Don't take Citron's word, look at the majority shareholders AI molecular simulation is real disruption. TGT- $80

👍️0
RodgeDodger RodgeDodger 4 years ago
Still running
👍️0
crudeoil24 crudeoil24 4 years ago
Schrodinger Shares Surge 55% After IPO Priced Above High End of Range >SDGR
12:39 pm ET February 6, 2020 (Dow Jones) Print
By Colin Kellaher

Shares of Schrodinger Inc. (SDGR) jumped more than 55% in their trading debut Thursday after the drug discovery software company's upsized initial public offering of 11.9 million shares was priced at $17 apiece, above the expected range.

Schrodinger shares recently were trading at $26.54, up about 56%, after opening at $26.

The New York company, whose investors include D.E. Shaw and the Bill & Melinda Gates Foundation, previously said it planned to sell 10 million shares at $14 to $16 each in the IPO.

The company has granted the underwriters an option to buy up to 1.78 million additional shares.
👍️0
crudeoil24 crudeoil24 4 years ago
Schrodinger Inc is headquartered in New York City, New York, United States and is a software publisher. The company's key areas of interest are Computational Chemistry Software, Molecular Modeling, Dockings, Homology Modeling, Cheminformatics, Pharmacophore Modeling, Qsars, Computational Biology, Computer Chemistry, Quantum Chemistry, Software For Chemistry. The company was founded in 1995.

👍️0

Your Recent History

NASDAQ
SDGR
Schrodinger
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved